Sign in

CIK 0001728328

  • Emerging growth company

InMed Pharmaceuticals Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 604-669-7207
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
  1. 4 Open-market buy 10% owner bought 91,101 shares at an average $1.30 ($118,076)
  2. S-4/A Deal Registration Statement - Business Combination
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 10-K Report Annual Report
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 8-K Event Regulation FD disclosure · Other events
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 4 Open-market buy 10% owner bought 1,000 shares at $1.56 ($1,555)
  11. 4 Open-market buy 10% owner bought 20,546 shares at $1.55 ($31,846)
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 8-K Event Material agreement · Regulation FD disclosure
  14. 4 Open-market buy 10% owner bought 6,551 shares at an average $1.55 ($10,148)
  15. S-4 Deal Registration Statement - Business Combination
  16. SCHEDULE 13D Stake Beneficial Ownership Report
  17. 4 Open-market buy 10% owner bought 249,227 shares at an average $1.57 ($391,555)
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Other events
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 3 of 27 · 537 filings